Log In
Print
BCIQ
Print
Print this Print this
 

Sevikar HCT, Tribenzor, olmesartan/amlodipine/hydrochlorothiazide (CS-8635)

  Manage Alerts
Collapse Summary General Information
Company Daiichi Sankyo Co. Ltd.
DescriptionFixed-dose combination of olmesartan, an angiotensin II receptor blocker, amlodipine, a dihydropyridine calcium channel blocker, and hydrochlorothiazide, a diuretic
Molecular Target Calcium channel
Mechanism of ActionCa channel blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today